Real-time enrollment status for this liver cancer clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 5:20 PM UTC
| NCT Number | NCT04634357 |
| Recruiting Status | Recruiting |
| Condition | Liver Cancer |
| Phase | PHASE1 |
| Target Enrollment | 12 participants |
| Active Locations | 4 sites in the US |
| Sponsor | Eureka Therapeutics Inc. |
| Last Updated on CT.gov | July 6, 2026 (Jul 6, 2026) |
As of October 12, 2026: Clinical trial NCT04634357 is currently recruiting participants. This phase1 study for liver cancer is actively seeking new participants at 4 locations across the United States. The study is sponsored by Eureka Therapeutics Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04634357 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 4 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04634357 was last updated Jul 6, 2026 (July 6, 2026). HelloStudys verifies this status automatically.